Literature DB >> 31530485

Cost-effectiveness analysis of a surveillance program to prevent hip dislocation in children with cerebral palsy.

Laura Vallejo-Torres1, Amado Rivero-Santana2, Carlos Martin-Saborido3, David Epstein4, Lilisbeth Perestelo-Pérez5, Carmen Luisa Castellano-Fuentes6, Antonio Escobar-Martínez7, Pedro Serrano-Aguilar5.   

Abstract

OBJECTIVE: In this study we conducted an economic evaluation of a surveillance programme to prevent hip dislocation in children with cerebral palsy.
METHOD: We developed a model that compared costs and health outcomes of children with cerebral palsy with and without a surveillance programme. Information from a number of sources was combined into a decision analytical model, primarily based on data from a comparative study with a 20-year follow-up. Effectiveness was measured using Quality-Adjusted Life Years (QALYs). The analysis took the perspective of the Spanish National Health Service. We undertook extensive sensitivity analyses including a probabilistic sensitivity analysis.
RESULTS: The surveillance programme led to higher QALYs and higher health care costs, with an estimated incremental cost per QALY gained of 12,282€. The results were robust to model assumptions. The probability that the programme was cost-effective was estimated to be over 80% at the threshold of 25.000€/QALY recommended in Spain.
CONCLUSION: This study indicates that surveillance programmes to prevent hip dislocation in children with cerebral palsy are likely to be cost-effective.
Copyright © 2019 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Análisis coste-beneficio; Cerebral palsy; Cost-benefit analysis; Hip dislocation; Luxación de cadera; Parálisis cerebral

Year:  2019        PMID: 31530485     DOI: 10.1016/j.gaceta.2019.05.005

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  1 in total

1.  Prevalence and treatment of hip displacement in children with cerebral palsy in Finland.

Authors:  Ira Jeglinsky; Ann I Alriksson-Schmidt; Gunnar Hägglund; Matti Ahonen
Journal:  J Child Orthop       Date:  2022-04-30       Impact factor: 1.917

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.